iBio
IBIO
#10451
Rank
C$57.34 M
Marketcap
C$1.15
Share price
3.14%
Change (1 day)
-53.21%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): C-$1.06

According to iBio's latest financial reports the company's current EPS (TTM) is C-$1.05. In 2025 the company made an earnings per share (EPS) of C-$2.45 an increase over its 2024 EPS that were of C-$9.09.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.06-56.5%
2025C-$2.45-73.08%
2024C-$9.09-93.88%
2023C-$148.57-8.14%
2022C-$161.7492.67%
2021C-$83.95-80.33%
2020C-$426.73-35.11%
2019C-$657.58-38.96%
2018C-$1,077-6.1%
2017C-$1,14736.67%
2016C-$839.4733.33%
2015C-$629.6050%
2014C-$419.73-53.85%
2013C-$909.42-7.14%
2012C-$979.38-64.1%
2011C-$2,72877.27%
2010C-$1,539144.44%
2009C-$629.6012.93%
2008C-$557.5212.2%
2007C-$496.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.22-1,264.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
C-$0.73-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C-$9.37 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$4.81 358.67%๐Ÿ‡บ๐Ÿ‡ธ USA